 random clinic studi calcium-entri blocker lidoflazin treatment comatos survivor cardiac arrest brain resuscit clinic trial II studi group background abnorm cellular calcium homeostasi pathophysiolog postischem encephalopathi calcium-entry-block drug influx calcium cell postischem encephalopathi anim model method hundr twenti patient cardiac arrest restor spontan circul dose lidoflazin experiment calcium-entri blocker placebo month patient follow-up treat patient intraven load dose mg kilogram bodi weight lidoflazin subsequ dose mg kilogram hour resuscit investig treatment assign result signific differ lidoflazin group placebo group proport patient six-month follow-up percent good cerebr recoveri percent sever neurolog deficit percent analysi level recoveri time follow-up differ treatment group percent lidoflazin percent placebo good cerebr function normal disabl cerebr perform time conclus administr lidoflazin cardiac arrest benefici data routin use calcium-entry-block drug comatos survivor cardiac arrest